CICERO [COVID-19]
Research type
Research Study
Full title
CICERO - Covid-19 in vitro diagnostic near-patient testing in Care Environments using a Randomised Open-label trial design in an East London nursing home population
IRAS ID
285524
Contact name
Joanne Martin
Contact email
Sponsor organisation
Queen Mary University London
ISRCTN Number
ISRCTN12345678
Clinicaltrials.gov Identifier
Duration of Study in the UK
0 years, 3 months, 6 days
Research summary
COVID-19 infection rates have been particularly high in care homes. Lots of work is going to try to reduce this. Key parts of reducing any spread of infection is to identify who is infected, and then to be able to separate them from others, and use protective equipment, so they dont spread it to others. The testing for the virus is typically done by taking a swab from the nose and throat, and then sending it to a laboratory for analysis. Current methods can take 24-48 hours to get a result back. The q16 equipment is a way of bringing the test equipment to the place you need it, and is faster than the routine testing, so that you can get the result back in 2 hours. We want to to the new pathway, so that we can show that the speed of the testing can help reduce the infection rate in the care homes, but getting the separation and protection methods in place faster.
REC name
West Midlands - Black Country Research Ethics Committee
REC reference
20/WM/0194
Date of REC Opinion
2 Jul 2020
REC opinion
Further Information Favourable Opinion